Prof De Bruin’s seminar was entitled “Is pharmaceutical legislation fostering or hampering innovation? Examples from Drug Regulatory Science”.

Prof De Bruin is a professor in Drug Regulatory Science at Utrecht University, the Netherlands and scientific director of the Utrecht Centre for Pharmaceutical Policy and Regulation. She has combined academic research with working for the regulatory authorities since 2008, both nationally (Pharmacovigilance expert for the Dutch Medicines Evaluation Board 2008-2016) and internationally (European Commission appointed independent Scientific Expert of the Pharmacovigilance Risk Assessment Committee (PRAC), at the European Medicines Agency 2012-2018).

Marieke has a strong background in epidemiology, and was a member of the steering group of the European Network of Centers for Pharmaco­epidemiology and Pharmacovigilance (ENCePP 2017-2019).